World TeamTennis Accepting Applications for Novo Nordisk Donnelly Award Scholarships
FOR IMMEDIATE RELEASE
Contact: Rosie Crews
1402 Toplea Drive
Euless,
817-684-0366
rcrews@wtt.com
01/10/07 - New York, N.Y.--World TeamTennis is currently accepting applications for the Novo Nordisk Donnelly Awards, two one-time $5,000 scholarships given annually to two young people, ages 14-21, who have diabetes and play tennis competitively in tournaments or on their school team.
The awards are sponsored by Novo Nordisk, a world leader in diabetes care, and are to be used for education, tennis development and/or medical care.
Applications must be received by May 1, 2007, along with two letters of recommendation and a short essay regarding the significance of diabetes in the applicant’s life. For more details on the Novo Nordisk Donnelly Awards and to download an application form, visit www.WTT.com. For more information, contact Diane Donnelly Stone at dstone@wtt.com or 212-586-3444, x. 20.
In addition to their scholarships, the recipients receive an expense-paid trip to a World TeamTennis Pro League match during the summer of 2007 to receive their awards from WTT co-founder Billie Jean King.
Established by King, through WTT Charities, in 1998 to encourage children with diabetes to lead an active life and compete in tennis, the Novo Nordisk Donnelly Awards provide scholarships to young tennis players carrying the burden of diabetes. The awards are named after two long-time World TeamTennis executives and tennis champions, Diane Donnelly Stone and Tracey Donnelly Maltby, who are sisters. Stone was an All-American and NCAA doubles champion at Northwestern University, and Maltby earned All-Big Ten honors at the University of Iowa. Both women have lived successfully with diabetes since childhood.
Novo Nordisk is a healthcare company with an 80-year history of innovation and achievement in diabetes care. Novo Nordisk is changing diabetessm. Changing Diabetes means helping people with actions and not just products. Novo Nordisk is committed to improving options for care now while partnering with others who share the Novo Nordisk corporate mission and ultimate goal of defeating this disease.
# -
Media Contacts: WTT – Rosie Crews, 817.684.0366 (rcrews@wtt.com)
Links:
http://www.wtt.com
